|
Items in cart [0] |
Questions? Call 888-624-8373 |
HARDBACK + PDF HARDBACK PDF BOOK PDF CHAPTERS Free Resources |
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. NIH heroin addiction treatment guidelines, 209 outcome monitoring, 153-160 passim, 167, 168, 169 pregnant women, 36 Alcohol and Drug Research Study, 37 Alcohol and Drug Services Survey, 187-197 Alcoholics Anonymous, 24, 27-29, 85, 138, 140, 160, 162-164, 169, 175 Aliviane, 77 American Cancer Society, 46 American Heart Association, 46 American Lung Association, 46 American Medical Association, 62, 200 American Psychiatric Association, 61 American Society of Addiction Medicine, 61, 100, 161 Amphetamines, see Methamphetamines Antabuse (disulfiram), 167, 169, 242 Antidepressants, 170 Anxiolytic buspirone, 170 Arapaho House Comprehensive Substance Abuse Treatment Center, 73-75, 78, 79, 82 Arizona, 20 ASI, see Addiction Severity Index Asians/Pacific Islanders, 139, 194, 244 Assessment methodology, see Evaluation methodology; Quality control Attitudes, vi AA members, 27-29 abuser motivation, 33, 50, 80, 156-157, 162, 163, 175, 235, 241-242, 247 contingency management, 34 methadone maintenance, 32, 49-50 self-esteem, 80 stigma, 9, 11, 16, 17, 25, 32, 46-48, 49-50, 116, 153, 205, 210, 213 treatment facilities placement, local residents, 38, 46, 47, 49-50 trust building, xv, 3, 5, 56, 57, 66-70, 74, 98, 112 B Barbiturates, 194 Behavioral interventions, 2, 6, 7, 18, 19, 20, 24, 59, 67, 74, 86, 150, 164-165, 170-171 NIH heroin addiction treatment guidelines, 202, 208, 209 see also Contingency management; Counseling and counselors; Group therapy Benzodiazepines, 194 Biopsychological factors, vii,6, 16, 17, 80 methamphetamine abuse, 229 opiate addiction, 200-201, 203-204, 212 outcome analysis, 152 recovering addicts, 149 see also Drugs to treat abusers; Genetic factors; Medical interventions; Mental illness; Withdrawal Black persons, see African Americans Block grants, 7, 17, 27, 42-43, 65, 114, 197 methadone, 31 Buprenorphine, 49, 151, 166, 207, 209 C Cancer treatment, 11, 46, 68-69, 96, 100-102, 107 cost-effectiveness, 5, 101, 112 see also Community Clinical Oncology Program Case management, 34, 74, 97, 173, 238, 248, 250 CASPAR, 102 CBOs, see Community-based drug treatment organizations CCOP, see Community Clinical Oncology Program Center for Mental Health Services, 95 Center for Substance Abuse Prevention, 94-95 Center for Substance Abuse Treatment, v, vii, 9, 17-18, 116, 124, 231 collaborative research support, 10, 13-15, 18, 74, 94, 100, 117-118, 120 definitional issues, 23 technology transfer, 58, 59-60, 115, 120, 136 treatment protocols, list of approved, 233-234 Center on Alcohol, Substance Abuse, and Addiction, 20, 96, 98-99, 108 Certification, see Licensing and certification
|
|
|||||||||||||||
